Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

54
Pharmaceutical
40
Pharmaceutical Manufacturers
30
Prescription Drugs
25
Patents
25
Pharmaceutical Patents
23
ANDA
18
SCOTUS
15
Hatch-Waxman
14
Labeling
13
Preemption
12
Biosimilars
11
Drug Manufacturers
11
FDCA
9
Patent Infringement
8
Failure To Warn
8
Medical Devices
7
Antitrust Litigation
7
Patent Litigation
7
Reverse Payment Settlement Agreements
6
Warning Labels
5
Affordable Care Act
5
Appeals
5
BPCIA
5
Design Defects
5
Healthcare
5
Manufacturers
5
Product Hopping
4
FTC
4
FTC v Actavis
4
Mutual Pharmaceuticals v Bartlett
4
Mylan Pharmaceuticals
4
Orphan Drugs
4
Otsuka Pharmaceutical
4
PLIVA v Mensing
4
Popular
4
Teva Pharmaceuticals
3
Apotex
3
GDUFA
3
Medicaid
3
Pharmacies
3
Safe Harbors
3
Watson Pharmaceuticals
2
Actavis Inc.
2
Antitrust Provisions
2
Biologics Price Competition and Innovation Act of 2009
2
China
2
Citizen Petitions
2
Class Action
2
Classen Immunotherapies
2
Clinical Trials
2
Corporate Counsel
2
Duty to Deal
2
Food Safety
2
Healthcare Reform
2
Inter Partes Review Proceedings
2
Medicare
2
Mensing
2
OIG
2
Prior Art
2
Product Exclusivity
2
Professional Conferences
2
Proposed Regulation
2
Sandoz
2
Summary Judgment
2
Trademarks
2
Unfair Competition
1
Abbott Laboratories
1
AbbVie
1
ACOs
1
Advanced Premium Tax Credits
1
Amended Complaints
1
America Invents Act
1
Amgen
1
Antitrust Injuries
1
Approval
1
AstraZeneca
1
Australia
1
Biogen Idec
1
Biopharmaceutical
1
Biotechnology
1
Books
1
BPCI
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
Canada
1
Cartwright Act
1
Carve Out Provisions
1
CDC
1
Chevron Deference
1
Cipro
1
CMS
1
Competition
1
Contraceptive Coverage Mandate
1
Copyright
1
Copyright Infringement
1
Cost-Sharing
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
DaimlerAG
1
Declaratory Judgments
1
Defect
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
DOHA
1
DOJ
1
DQSA
1
Draft Guidance
1
Drug Compounding
1
Drug Safety
1
Durable Medical Equipment
1
EAR
1
EHR
1
Elan Pharmaceuticals
1
Enforcement
1
EU
1
Exceptional Case
1
Exclusivity
1
Exports
1
False Advertising
1
False Claims Act
1
First Sale Doctrine
1
Food Labeling
1
Food Recalls
1
Foreign Manufacturers
1
Generic
1
Gilead Sciences
1
GlaxoSmithKline
1
Government Investigations
1
HHS
1
Highmark v. Allcare
1
Hoffman LaRoche
1
Hospitals
1
Imports
1
Information Reports
1
Informed Consent
1
Intellectual Property Litigation
1
International Treaties
1
INTERPOL
1
IRF Claim Processing
1
Jurisdiction
1
Justiciable Controversy
1
Kickbacks
1
Legislative Agendas
1
Licenses
1
Life Sciences
1
Manufacturing Defects
1
Medical Device Amendments
1
Medicare Part D
1
MedPAC
1
Medtronic
1
Medtronics
1
Merck
1
Misrepresentation
1
Monopolization
1
Mootness
1
Naming Conventions
1
New Guidance
1
New Regulations
1
NIH
1
Nike
1
Non-Grandfathered Health Plans
1
Novartis
1
Nursing Homes
1
Nutritional Supplements
1
Octane Fitness v. ICON
1
Orange Book
1
Patent Applications
1
Patent Trial and Appeal Board
1
Patent-in-Suit
1
Pay-For-Delay
1
PHRMA
1
Post-Grant Review
1
Preliminary Injunctions
1
Premarket Approval Applications
1
Product Labels
1
Proposed Legislation
1
Public Meetings
1
Public Performance Rights
1
Putative Class Actions
1
Qui Tam
1
Rebates
1
Recordkeeping Requirements
1
REMS
1
Rule-of-Reason Analysis
1
Rulemaking Process
1
Settlement
1
Sherman Act
1
Standard of Review
1
Standing
1
Tax Credits
1
Trade Secrets
1
Transfer of Venue
1
TRO
1
USPTO
1
Vaccinations
1
Veterinary Products
1
Websites
1
Whistleblowers
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
WTO
1
Wyeth